Back to search

National and Kapodistrian University of Athens

Προγνωστικοί και προβλεπτικοί της θεραπείας παράγοντες σε όγκους αρχέγονων γεννητικών κυττάρων

Abstract

dc:description

Germ cell tumors and especially testicular cancer is the most common malignancy in young male 20-35 years old. Recent advances are oriented in risk prediction models, in order to identify poor risk patients that will not respond to chemotherapy, or relapse, candidates for intense chemotherapeutic regimens, and good risk patients that minimal toxicity is the point. The identification, at a molecular level, of factors or pathways that may have prognostic value on the efficacy of chemotherapy and therefore on survival, is crucial in order to rationalize treatment success. The aim of this study is to assess the prognostic significance of immunohistochemical markers that correlate with cellular proliferation and growth (p53, MIB-1, c-KIT), cellular death (p53, bax, bcl-2), angiogenesis (COX-2) and chemoresistance (topoisomerase IIa, p53). One hundred seventy-seven patients with the diagnosis of germ cell tumor and paraffin embedded tissue available are included in the study. The mean age of the population was 28 years (range 16-75 years). According to the IGCCCG classification, 129 patients were good risk, 28 were intermediate risk and 20 were poor risk. From the studied markers, p53 (HR 4.01, 95% CI 1.25-12.84, p=0.019) and MIB-1 (HR 3.16, 95% CI 1.06-9.45, p=0.039) were associated with overall survival. The best cut-off values were 10% for p53 and 30% for ΜΙΒ-1, with specificity of 75-85% and sensitivity of 50-60%. The combination of the two markers was correlated with the pathological stage, the primary site and the IGCCCG classification. Multivariate analysis, including all the above mentioned parameters plus chemotherapy regimen showed that the immunohistochemical combination (HR 6.63, 95% CI 1.40-31.41, p=0.017) and the IGCCCG classification (HR 7.99, 95% CI 1.96-32.52, p=0.004) are independently associated with survival. Conclusively, the combination of p53 and MIB-1 could be used in conjunction with the IGCCCG classification for more accurately defining risk in germ cell cancer patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Nikolaou, Maria
  • Νικολάου, Μαρία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27856

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Nikolaou, Maria; Νικολάου, Μαρία. Προγνωστικοί και προβλεπτικοί της θεραπείας παράγοντες σε όγκους αρχέγονων γεννητικών κυττάρων. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27856